National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies
Page 13 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.
- Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive AdultsCompletedNCT00820846Phase 2
- Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat TuberculosisCompletedNCT00816426Phase 1
- Cytomegalovirus Cell-Mediated ImmunityCompletedNCT00815165
- Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gammaActive, not recruitingNCT00814827
- Treatment With hOKT3gamma1(Ala-Ala) in T1DMTerminatedNCT00806572Phase 2
- Normal Blood, Bone Marrow and Buccal Mucosa ProtocolCompletedNCT00806364
- Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected ChildrenCompletedNCT00802802Phase 1
- Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 VectorCompletedNCT00801697Phase 1
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney TransplantWithdrawnNCT00790439Phase 2
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet TransplantationCompletedNCT00789308Phase 2
- Hepatitis B and HIV Co-Infection in Patients in UgandaCompletedNCT00782158
- Vaccine for Prevention of Bird FluCompletedNCT00776711Phase 1
- Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected AdultsCompletedNCT00776412
- Immune Parameters in the Cord Blood of Newborns Exposed to Malaria in the WombCompletedNCT00772642
- Safety of Immunosuppression Minimization in Children and Adolescents After Kidney TransplantationCompletedNCT00768729Phase 1
- High Dose Influenza in Immunosuppressed SubjectsWithdrawnNCT00766285Phase 2
- Malaria Challenge With NF54 StrainCompletedNCT00744133Phase 1
- Malaria Vaccine for Children in MaliCompletedNCT00740090Phase 1
- Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine VaccineCompletedNCT00734175Phase 1
- Bone Mineral Density Substudy - An Ancillary Study to MTN-003CompletedNCT00729573
- Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus VaccineCompletedNCT00722774Phase 1
- Cause of Unexplained AnaphylaxisCompletedNCT00719719
- Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy AdultsCompletedNCT00712803Phase 1
- Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector InjectionCompletedNCT00709605Phase 1
- Pertussis Vaccine in Healthy Pregnant WomenCompletedNCT00707148Phase 1
- Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent FemalesStatus unknownNCT00706368Not applicable
- Response to Standard HIV Treatment in Bamako, MaliCompletedNCT00703404
- Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy AdultsCompletedNCT00695877Phase 1
- H5N1 (Clade 2) Vaccination of Adults and ElderlyCompletedNCT00680069Phase 1/2
- Study of Provider Computer Alerts Designed to Improve Delivery of HIV CareCompletedNCT00678600Not applicable
- Rapid HIV Testing for Emergency Department PatientsCompletedNCT00676481Not applicable
- Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in ThailandCompletedNCT00672412Phase 1/2
- Innate and Acquired Resistance to Plasmodium Falciparum Malaria in MaliCompletedNCT00669084
- Malaria Studies in CambodiaCompletedNCT00663546
- Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)CompletedNCT00660972Phase 1
- Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult SubjectsCompletedNCT00654108Phase 1
- Poly-ICLC to Prevent Respiratory Viral Infections A Safety StudyCompletedNCT00646152Phase 1
- Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus VaccineCompletedNCT00641017Phase 1
- Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in UgandaCompletedNCT00639938Phase 3
- Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy AdultsCompletedNCT00618605Phase 1
- H9 Priming Study in Healthy AdultsCompletedNCT00617331Phase 2
- Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal RouteCompletedNCT00614731Phase 1
- Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young AdultsWithdrawnNCT00614640Phase 1/2
- Genomics of Chronic Renal Allograft Rejection (The GoCAR Study)CompletedNCT00611702
- Dyskinesia, Heterotaxy and Congenital Heart DiseaseCompletedNCT00608556
- Live Kidney Donor StudyCompletedNCT00608283
- Ebola and Marburg Virus VaccinesCompletedNCT00605514Phase 1
- MRI to Measure Liver Fat ContentCompletedNCT00594412Not applicable
- Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected WomenCompletedNCT00594373Phase 1
- ICC-1132 - Candidate Vaccine Against P Falciparum MalariaCompletedNCT00587249Phase 1
- HIV Resistance and Treatment StrategiesCompletedNCT00581802
- An Interventional Study of Milk AllergyCompletedNCT00578656Early Phase 1
- Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative AdultsCompletedNCT00574600Phase 1
- Safety, Reactogenicity and Immunogenicity of MVA in Hematopoietic Stem Cell Transplant (HSCT) SubjectsCompletedNCT00565929Phase 1
- LCI Apheresis to Obtain Plasma or White Blood CellsTerminatedNCT00562601
- Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory DisordersTerminatedNCT00557895
- Evaluation and Monitoring of Patients With HIV InfectionnCompletedNCT00557570
- Live Lung Donor Retrospective StudyCompletedNCT00553397
- Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy AdultsCompletedNCT00546585Phase 1/2
- Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean DeliveryCompletedNCT00540605Phase 1
- Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy AdultsCompletedNCT00537147Phase 1
- SARS Coronavirus Vaccine (SARS-CoV)WithdrawnNCT00533741Phase 1
- Influenza in People With Normal and Weakened Immune SystemsCompletedNCT00533182
- Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant SurvivalCompletedNCT00531921
- Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy AdultsCompletedNCT00528489Phase 1
- Proleukin and Rapamune in Type 1 DiabetesCompletedNCT00525889Phase 1
- SARS Survivor EvaluationsWithdrawnNCT00523276
- Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn InfantsStatus unknownNCT00516360Phase 4
- Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy AdultsCompletedNCT00516035Phase 1
- Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic DermatitisCompletedNCT00515047
- Medical Treatment of Colitis in Patients With Hermansky-Pudlak SyndromeWithdrawnNCT00514982Phase 2
- Malaria Incidence in Infants in Bancoumana, MaliCompletedNCT00508417
- Chiron Corp HCV E1/E2 VaccineCompletedNCT00500747Phase 1
- Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and AfricaWithdrawnNCT00498056Phase 2
- Collection of Samples and Data for the National Marrow Donor Program RepositoryCompletedNCT00495300
- Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given IntradermallyCompletedNCT00489931Phase 1
- An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected IndividualsCompletedNCT00489385Phase 1
- Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy AdultsCompletedNCT00488046Phase 1
- Phase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium FalciparumCompletedNCT00487916Phase 1
- Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected AdultsCompletedNCT00486408Phase 1
- Phase 1 Safety Study of Two Experimental HIV VaccinesCompletedNCT00479999Phase 1
- Pneumococcal Reference StandardCompletedNCT00479323Phase 1
- A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, ChinaCompletedNCT00479141Not applicable
- Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus VaccineCompletedNCT00473135Phase 1
- Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy AdultsCompletedNCT00472719Phase 1
- Pathogenesis of Liver Fluke Induced Cancer in ThailandCompletedNCT00472602
- Medical Implications of Coinfection With Malaria and Filariasis ParasitesCompletedNCT00471666
- Normal Immunological Parameters Among Healthy Volunteers in Kambila, MaliCompletedNCT00471302
- B-Lymphocyte Immunotherapy in Islet TransplantationTerminatedNCT00468442Phase 2
- LEA29Y (Belatacept) Emory Edmonton ProtocolCompletedNCT00468403Phase 2
- Efficacy of Islet After Kidney TransplantationCompletedNCT00468117Phase 3
- Noninvasive Methods to Monitor Graft Survival in Heart Transplant PatientsCompletedNCT00466804
- Plasmodium Resistance in A. GambiaeCompletedNCT00466557
- Strategies to Improve Islet SurvivalCompletedNCT00464555Phase 2
- Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue VirusCompletedNCT00458120Phase 1
- TG4040 in Patients With Chronic HCVWithdrawnNCT00449124Phase 1
- Phase I Study of Safety and Persistence of UC-781 Vaginal MicrobicideCompletedNCT00441909Phase 1
- Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic DermatitisCompletedNCT00438022
- Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in FijiCompletedNCT00436891
- Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 DiabetesCompletedNCT00434850Phase 2
← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas